Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07220577 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07220577
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-10
- Primary completion
- 2027-05-17
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.